Executive Summary
This RAND report explores expanding the Federal Select Agent Program (FSAP) to oversee nucleic acids, including genomes, genes, and gene fragments. It analyzes existing statutory frameworks to determine if FSAP can regulate these materials, particularly those from biological select agents and toxins (BSAT) and non-BSAT agents. The study identifies potential regulatory paths without requiring significant statutory amendments, proposing a new 'Tier 3' for genetic elements posing significant public health risks.
Why It Matters
This document is crucial for defense and geopolitical analysts as it outlines potential expansions of biosecurity regulations, directly impacting the control of dangerous biological materials and the strategic implications of synthetic biology advancements. Understanding these regulatory frameworks is vital for assessing national security risks and policy responses related to biological weapons and pandemics.
Key Takeaways
- FSAP could expand its regulatory oversight to include various genomes, genes, and gene fragments from both BSAT and non-BSAT agents without major statutory changes.
- A new 'Tier 3' oversight framework is proposed for genetic elements that pose significant public health risks but are not currently regulated as full agents.
- The report emphasizes balancing enhanced biosecurity with minimizing undue burdens on the scientific research community, a critical consideration for future policy implementation.
Strategic Relevance
The expansion of biosecurity regulations to cover genetic materials is strategically important for preventing the misuse of synthetic biology for biological weapons development or accidental pandemic creation. It directly addresses the evolving threat landscape posed by rapid technological advancements in life sciences, aiming to enhance national and global security against biological threats.